Meta menu:

From here, you can access the Emergencies page, Contact Us page, Accessibility Settings, Language Selection, and Search page.

Open Menu
Ein Bücherregal; Foto: Charité

Publications of the members of the AG Hoffmann

You are here:

Publication list

S. Koch, C. Hoffmann, A. Caseiro, M. Ledebur, M. Menk, E. von Schneidemesser. “Air quality in Germany as a contributing factor to morbidity from COVID-19”, Jul. 2022, Environ. Res., 214(Pt 2):113896, DOI: 10.1016/j.envres.2022.113896

C. Hoffmann, M. Maglakelidze, E. von Schneidemesser, C. Witt, P. Hoffmann, T. Butler. “Asthma and COPD exacerbation in relation to outdoor air pollution in the metropolitan area of Berlin, Germany”, Mar. 2022, Respir. Res., 23(1):64, DOI: 10.1186/s12931-022-01983-1

C. Hoffmann, U. Liebers, P. Humbsch, M. Drozdek, G. Bölke, P. Hoffmann, A. Holzgreve, G. C. Donaldson, C. Witt. “An adaptation strategy to urban heat: Hospital rooms with radiant cooling accelerate patient recovery”, Aug. 2021, ERJ Open Res., 7: 00881-2020, DOI: 10.1183/23120541.00881-2020

B. Lenzer, C. Hoffmann, P. Hoffmann, U. Müller-Werdan, M. Rupprecht, C. Witt, C. Herzig, U. Liebers. “A qualitative study on concerns, needs and expectations of hospital patients related to climate change: Arguments for a patient-centred adaptation”, Jun. 2021, Int. J. Environ. Res. Public Health, 18(11): 6105, DOI: 10.3390/ijerph18116105

B. Lenzer, M. Rupprecht, C. Hoffmann, P. Hoffmann, U. Liebers. “Health effects of heating, ventilation and air conditioning on hospital patients: a scoping review”, Aug. 2020, BMC Public Health, 20:1287, DOI: 10.1186/s12889-020-09358-1

C. Hoffmann. “Vulnerabilität von COPD-Patienten für Hitzestress und Luftbelastung - Umwelteinflüsse treiben die Hospitalisierungsrate”, Jan. 2020, Der Klinikarzt, 49(01/02): 10-13, DOI: 10.1055/a-1078-8039

C. Hoffmann, M. Hanisch, J.B. Heinsohn, V. Dostal, M. Jehn, U. Liebers, W. Pankow, G.C. Donaldson, C. Witt. “Increased vulnerability of COPD patient groups to urban climate in view of global warming”, Oct. 2018, Int. J. Chron. Obstruct. Pulmon. Dis., 13: 3493-3501, DOI: 10.2147/COPD.S174148

C. Hoffmann, P. Hoffmann, M. Zimmermann. “Diagnostic testing for a high-grade inflammation: parameter dynamics and novel markers”, Mar. 2015, Clin. Chem. Lab. Med., 53: 541-547, DOI: 10.1515/cclm-2014-0482

M. Zimmermann, M. Cremer, C. Hoffmann, K. Weimann, A. Weimann. “Granularity Index of the SYSMEX XE-5000 hematology analyzer as a replacement for manual microscopy of toxic granulation neutrophils in patients with inflammatory diseases”, Jul. 2011, Clin. Chem. Lab. Med., 49: 1193-1198, DOI: 10.1515/CCLM.2011.188

P. Hoffmann, C. Hoffmann, R. Ziebig, M. Zimmermann. “Evaluation of the iChem Velocity Urine Chemistry Analyzer in a hospital routine laboratory”, Mar. 2011, Clin. Chem. Lab. Med., 49: 509-513, DOI: 10.1515/CCLM.2011.065

C. Hoffmann, P. Hoffmann, A. Lun, C. Büning, F. Hiepe, H.U. Scherer, E. Steinhagen-Thiessen, A. Weimann. “Is there a role for mannan-binding lectin in the diagnosis of inflammatory bowel disease?”, Apr. 2010, Immunogenetics, 62: 231-235, DOI: 10.1007/s00251-010-0429-0

P. Hoffmann, C. Hoffmann, A. Weimann. “Choice of plasmid preparation kit influences sequencing results.”, Mar. 2010, Biotechnol. Lett., 32: 421-422, DOI: 10.1007/s10529-009-0157-4

C. Schlaak, P. Hoffmann, K. May, A. Weimann. “Desalting minimal amounts of DNA for electroporation in E. coli: a comparison of different physical methods”, Jul. 2005, Biotechnol. Lett., 27: 1003-1005, DOI: 10.1007/s10529-005-7867-z

Further information on the research of the AG Hoffmann